BlackRock Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.17M Buy
142,051
+25,723
+22% +$503K ﹤0.01% 1889
2016
Q3
$2.16M Buy
116,328
+12,037
+12% +$227K ﹤0.01% 2095
2016
Q2
$1.7M Buy
104,291
+9,317
+10% +$137K ﹤0.01% 2236
2016
Q1
$1.11M Sell
94,974
-380
-0.4% -$4.25K ﹤0.01% 2415
2015
Q4
$1.11M Buy
95,354
+214
+0.2% +$2.71K ﹤0.01% 2526
2015
Q3
$1.17M Sell
95,140
-3,188
-3% -$40.6K ﹤0.01% 2495
2015
Q2
$927K Buy
98,328
+17,138
+21% +$159K ﹤0.01% 2820
2015
Q1
$719K Buy
81,190
+270
+0.3% +$2.73K ﹤0.01% 2755
2014
Q4
$812K Sell
80,920
-339
-0.4% -$2.91K ﹤0.01% 2685
2014
Q3
$545K Buy
81,259
+2,716
+3% +$19K ﹤0.01% 2922
2014
Q2
$563K Buy
+78,543
New +$625K ﹤0.01% 2982

Other funds holding BEAT

BlackRock Investment Management's BEAT Position: Q4 2016 in Review

BlackRock Investment Management increased its BioTelemetry, Inc. (BEAT) stake by 22% in Q4 2016, buying an estimated $503K and bringing the position to 142,051 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1889.

BlackRock Investment Management first reported a position in BEAT in Q2 2014 and has held it in 11 quarters since. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

  • BlackRock Investment Management held 142,051 shares of BioTelemetry, Inc. worth $3.17M as of Q4 2016.
  • BlackRock Investment Management bought 25,723 BioTelemetry, Inc. shares in Q4 2016, an estimated $503K.
  • BioTelemetry, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1889 holding.
  • BlackRock Investment Management first reported a position in BioTelemetry, Inc. in Q2 2014 and has held it in 11 quarters since.
  • 160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.